Arrowhead Pharmaceuticals, Inc.
Символ: ARWR
NASDAQ
23.78
USDПазарна цена днес
-8.6058
Съотношение P/E
-0.0408
Коефициент PEG
2.95B
MRK Cap
- 0.00%
Доходност на DIV
Arrowhead Pharmaceuticals, Inc. Структура на управлението
Информация за управлението
Име | Заглавие |
---|---|
Mr. Patrick O'Brien J.D., PharmD | Chief Operating Officer, General Counsel & Secretary |
Ms. Tracie Oliver | Chief Commercial Officer |
Dr. Vincent Anzalone CFA | Head of Investor Relations & Vice President |
Dr. James C. Hamilton M.D., MBA | Chief of Discovery & Translational Medicine |
Dr. Mark Seefeld | Head of Toxicology & Vice President |
Dr. Christopher R. Anzalone Ph.D. | Chief Executive Officer, President & Director |
Mr. Howard Lovy | Director of Communications |
Dr. Bruce D. Given M.D. | Chief Medical Scientist |
Dr. Mark M. Davis Ph.D. | Founder and Founder & Director of Insert Therapeutics Inc & Calando |
Mr. Kenneth A. Myszkowski | Chief Financial Officer |
Подобни акции
Може да се интересувате и от:CMRA
Топ мениджмънт:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
T5O.DE
Топ мениджмънт:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
PPBT
Топ мениджмънт:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Топ мениджмънт:
- Ms. Cheryl Maley...
- Mr. Justin Cahill
ARQT
Топ мениджмънт:
- Ms. Courtney Barton
- Ms. Ayisha Jeter
- Ms. Amanda Sheldon
ADTX
Топ мениджмънт:
- Mr. Ge Chen M.D....
- Dr. Dolly B. Tyan...
- Ms. Jennifer Lee